Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A sample size adjustment procedure for clinical trials based on conditional power.

Gang Li1, Weichung J Shih, Tailiang Xie

  • 1Organon Inc., 375 Mt Pleasant Ave., West Orange, NJ 07052, USA. G.Li@organoninc.com

Biostatistics (Oxford, England)
|August 23, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Macrophage apoptosis in advanced atherosclerosis.

Annals of the New York Academy of Sciences·2009
Same author

Calcium/calmodulin-dependent protein kinase II links ER stress with Fas and mitochondrial apoptosis pathways.

The Journal of clinical investigation·2009
Same author

Cripto-1 overexpression is involved in the tumorigenesis of nasopharyngeal carcinoma.

BMC cancer·2009
Same author

Range of motion and orientation of the lumbar facet joints in vivo.

Spine·2009
Same author

[Silencing of COX-2 in nasopharyngeal carcinoma cells with a shRNAmir lentivirus vector].

Nan fang yi ke da xue xue bao = Journal of Southern Medical University·2009
Same author

The risk of melamine-induced nephrolithiasis in young children starts at a lower intake level than recommended by the WHO.

Pediatric nephrology (Berlin, Germany)·2009

Clinical trial sample size adjustments are crucial due to uncertain treatment effects. This study proposes a new method for calculating additional sample size using conditional power, ensuring trial integrity.

Area of Science:

  • Clinical trial design
  • Biostatistics
  • Statistical inference

Background:

  • Clinical trial planning often faces uncertainty in treatment effect and variability assumptions.
  • This uncertainty can compromise the accuracy of initial sample size calculations.
  • Mid-course sample size adjustments are increasingly utilized to address these challenges.

Purpose of the Study:

  • To propose a novel procedure for calculating the additional sample size needed in clinical trials.
  • To adjust the final-stage critical value while protecting the overall type-I error rate.
  • To offer a more flexible approach to interim decision rules in clinical trial design.

Main Methods:

  • The proposed procedure calculates the additional sample size based on conditional power.

Related Experiment Videos

  • It directly uses the definition of conditional type-I error, avoiding special functions.
  • The final-stage test employs a likelihood ratio test for robust statistical inference.

    • Main Results:

    • The new procedure provides a direct method for sample size recalculation.
    • It maintains the overall type-I error rate, crucial for trial validity.
    • The method offers enhanced flexibility in setting interim decision rules.

    Conclusions:

    • The proposed procedure offers a practical and flexible approach to adaptive clinical trial design.
    • It directly addresses sample size uncertainties by utilizing conditional power.
    • This method enhances the reliability of clinical trial outcomes by protecting statistical integrity.